(Q43103489)

English

MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals

scientific article published in April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Baolin Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Yuedong Ma

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Rongsen Meng

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Zhaojun Xiong

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Chengxi Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Guangqin Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Aixia Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Yugang Dong

8

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Acta Biochimica et Biophysica Sinica

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

253-258

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Hypertrophy of the heart: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Cardiac myocyte cell cycle control in development, disease, and regeneration

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Ubiquitin-proteasome pathway as a new target for the prevention of restenosis

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Drug discovery in the ubiquitin-proteasome system.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

The ubiquitin-proteasome system: focus on the heart.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

A proteasome inhibitor confers cardioprotection

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Mitogen-activated protein kinases in heart development and diseases

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Cardiac hypertrophy: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMQ012

21 January 2018

Identifiers

10.1093/ABBS/GMQ012

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43103489&oldid=1980851275"